Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Blind, Open-Label Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral Insulin Formulation in Type 1 Subjects

NCT00867594 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00867594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Blind, Open-Label Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral Insulin Formulation in Type 1 Subjects
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
August 31, 2008
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brittle type i diabetes mellitus